Biolegend, 837801, Anti-Neurofilament Marker (pan-neuronal, cocktail) Antibody (Previously Covance catalog# SMI-311R)
100microl
Catalog Number: 837801
Send an RFQ.
Category
| Verified Reactivity | Human, Mouse, Rat |
|---|---|
| Antibody Type | Monoclonal |
| Host Species | Mouse |
| Formulation | Ascites Fluid (contains 0.01M sodium azide). |
| Preparation | Ascites |
| Concentration | The concentration is not quantified as this product is sold as undiluted crude mouse ascites fluid. The concentration might vary from lot-to-lot and an estimated concentration would be 1-3 mg/ml. |
| Storage & Handling | Store at -20°C. Upon initial thawing, apportion into working aliquots and store at -20°C. Avoid repeated freeze-thaw cycles to prevent denaturing the antibody. For long-term storage, keep the antibody at -80°C. |
| Application | IHC-P - Quality testedWB - VerifiedIHC-F, ICC - Reported in the literature, not verified in house |
| Recommended Usage | Each lot of this antibody is quality control tested by formalin-fixed paraffin-embedded immunohistochemical staining. For immunohistochemistry, a dilution range of 1:1000 - 1:5000 is suggested. For Western blotting, the suggested use of this reagent is 1:5000 - 1:10000 per ml. It is recommended that the reagent be titrated for optimal performance for each application. |
Unless otherwise stated, the minimum order amount is USD 1,000.
For orders below USD 1,000, an additional handling fee may apply, or we may arrange local delivery / local handover where available.
All quotations are subject to final confirmation, including product availability, lead time, batch information, shipping cost, and applicable export or handling requirements.
For quotation requests, please send an RFQ from website or contact:
Please send inquiries directly to us in the “To” field. Emails sent via BCC, mass mailing, or with unrelated recipients may be automatically filtered and will not be processed.
| Application Notes |
|---|
| SMI 311 has been selected to provide a specific marker for neurons in tissue sections and cultures. In contrast to individual antinonphosphoneurofilaments that identify different subset of neurons and are, therefore, especially suitable for defining anatomic and functional differences in normal and pathologic neurons, SMI 311 is a convenient marker for neurons in general and their differentiation from non-neuronal cells. SMI 311 provides an early marker of neuronal migration and differentiation in human fetal development yielding Golgi-like images without the disadvantages of lack of selectivity and poor specificity of the Golgi technique. In specifically delineating cell bodies and dendrites, SMI 311 has been used to trace the "inside-out gradient" of neuron production and differentiation. Pathologic conditions, such as undernutrition affect SMI 311-visualized soma size and dendritic arborization. |
| Application References(PubMed link indicates BioLegend citation) | Tsunoda I, Kuang LQ, Libbey JE, Fujinami RS. Axonal injury heralds virus-induced demyelination. Am J Path 162:1259-1269, 2003. (IHC-P) Ulfig N, Nickel J, Bohl J. Monoclonal antibodies SMI 311 and SMI 312 as tools to investigate the maturation of nerve cells and axonal patterns in human fetal brain. Cell Tissue Res 291:433, 1998. Frola E, et al. 2013. PLoS One 2:e56311. (IHC-F) Ivanovic A, et al. 2012. J. Cell Biol. 3:337. (IHC-F, WB) PubMed Petzold A, et al. 2011. Brain 134:464. (IHC-P, WB) PubMed Del Valle L,et al. Cancer Biol Ther.9:286. (IHC-P, ICC, WB) PubMed |
|---|
| Product Citations | Batiuk MY, et al. 2022. Sci Adv. 8:eabn8367. PubMed Yang J, et al. 2023. Brain Sci. 13:. PubMed Checri R, et al. 2023. Brain Commun. 5:fcad174. PubMed Nguyen LH, et al. 2022. Brain. 145:1310. PubMed Hsieh L, et al. 2016. Nat Commun. 7:11753. PubMed Ivanovic A, et al. 2012. J Cell Biol. 196:337-344. PubMed Baldassari S, et al. 2019. Acta Neuropathol. 138:885. PubMed Pallebage–Gamarallage M, et al. 2018. BMC Neurosci. 19:11. PubMed Needham BD, et al. 2022. Nature. 602:647. PubMed Barr JL, et al. 2021. Cells. 10:. PubMed Lee WS, et al. 2019. Ann Clin Transl Neurol. 6:1338. PubMed Valle L, et al. 2010. Cancer Biol Ther. 9:286-294. PubMed del Blanco B, et al. 2019. Cell Death Differ. 26:2208. PubMed Zub E, et al. 2019. FASEB J. 33:13998. PubMed Petzold A, et al. 2011. Brain. 134:464-483. PubMed Xia D, et al. 2022. Mol Neurodegener. 17:41. PubMed Hudry E, et al. 2019. Life Sci Alliance. 2:. PubMed |
|---|
| RRID | AB_2565383 (BioLegend Cat. No. 837801) AB_2565384 (BioLegend Cat. No. 837802) |
|---|
| Structure | Expected MW: medium or middle NF (NF-M) runs at 145-160 kD, and the heavy or highest NF (NF-H) runs at 200-220 kD |
|---|
| Cell Type | Mature Neurons |
|---|
| Biology Area | Cell Biology, Neuroscience, Neuroscience Cell Markers |
|---|
| Molecular Family | Intermediate Filaments |
|---|
| Gene ID | 474747444741 |
|---|
| UniProt | View information about Neurofilament Marker on UniProt.org |
|---|
| Clone | SMI 311 |
|---|
| Regulatory Status | RUO |
|---|
| Other Names | Neurofilament Marker |
|---|
| Previously | Covance Catalog# SMI-311R |
|---|
| Isotype | Mouse IgG1/Mouse IgM |
|---|